The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.
The OTC Drug And Dietary Supplement Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The OTC Drug And Dietary Supplement Market:
https://www.thebusinessresearchcompany.com/report/otc-drug-and-dietary-supplement-global-market-report
According to The Business Research Company’s OTC Drug And Dietary Supplement Global Market Report 2024, The otc drug and dietary supplement market size has grown strongly in recent years. It will grow from $310.97 billion in 2023 to $331.84 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increased number of fitness enthusiasts, demographic shifts and aging population, regulatory approvals and safety standards, pharmacy and retail expansions, marketing and advertising strategies.The otc drug and dietary supplement market size is expected to see strong growth in the next few years. It will grow to $438.93 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%.
An increase in pharmaceutical research and development (R&D) expenditure is expected to drive the OTC (over-the-counter) drug and dietary supplement market in the future. R&D investment involves the resources allocated by companies to develop, design, and improve their products. Higher expenditure in this area can lead to increased innovation and productivity in the development and formulation of OTC drugs and dietary supplements. For example, according to a report by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based pharmaceutical trade association, the European health industries invested approximately 41.5 billion euros ($44.47 billion) in R&D expenditure in 2021, up from 39.65 billion euros ($42.49 billion) in 2020. Therefore, the rise in pharmaceutical R&D expenditure is fueling growth in the OTC drug and dietary supplement market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12096&type=smp
The otc drug and dietary supplement market covered in this report is segmented –
1) By Category: Vitamin And Dietary Supplements, Cough And Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other Categories
2) By Dosage Form: Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Other Dosage Forms
3) By Application: Pharmacies, Grocery Stores, Vitamin And Health Food Stores, Online Pharmacies
Top Major Players
Pfizer Inc.,
Johnson & Johnson Ltd.,
Hoffmann-La Roche AG,
Merck & Co. Inc.,
AbbVie Inc.
The otc drug and dietary supplement market report table of contents includes:
1. Executive Summary
- OTC Drug And Dietary Supplement Market Characteristics
- OTC Drug And Dietary Supplement Market Trends And Strategies
- OTC Drug And Dietary Supplement Market – Macro Economic Scenario
- Global OTC Drug And Dietary Supplement Market Size and Growth
- OTC Drug And Dietary Supplement Market Segmentation
- OTC Drug And Dietary Supplement Market Regional And Country Analysis
………………..
- Key Mergers And Acquisitions In The OTC Drug And Dietary Supplement Market
- OTC Drug And Dietary Supplement Market Future Outlook and Potential Analysis
- Appendix
List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global OTC Drug And Dietary Supplement Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
…………….
Table 74: Pfizer Inc. Financial Performance
Table 75: Johnson & Johnson Ltd. Financial Performance
Table 76: F. Hoffmann-La Roche AG Financial Performance
Table 77: Merck & Co. Inc. Financial Performance
Table 78: AbbVie Inc. Financial Performance
Read Related Reports :
https://topprnews.com/genotyping-market-trends/
https://goodprnews.com/genotyping-market-growth/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
